Home / Fact sheets / Uruguay / Colorectal qualitative data
Check also the following factsheets: Uruguay, Breast, Cervical
Country fact sheet: Uruguay
COLORECTAL CANCER SCREENING PROGRAMME
Reporting year for qualitative data: | 2021 |
Source of qualitative data: | Directly from Programme |
Organization of screening | |
An individual/team/institution responsible to coordinate the programme: | Yes |
Dedicated budget for screening programme: | No |
Documented cancer screening policy: | Yes |
Nature of documentation of the policy: | Notification |
Year programme was initiated: | 2001 |
Programme introduction was preceded by a pilot: | Yes, but pilot not evaluated |
Screening tests provided free of charge: | Yes |
Diagnostic tests provided free of charge: | No |
Treatment services provided free of charge: | No |
Information system and data collection | |
System that collects data: | Individual & Aggregated |
• Identification of eligible population: | No |
• Screening participation: | Individual & Aggregated |
• Screening test results: | Individual & Aggregated |
• Further assessment: | Aggregated |
• Final pathology diagnosis: | No |
• Cancer staging: | No |
• Treatment: | No |
The information system exists at national or sub-national level: | Individual: National Aggregated: National |
The information system collects data outside the programme (opportunistic screening/private sector): | Yes |
Cancer screening data is linked with population-based cancer registry (PBCR): | No |
Screening protocol | |
A screening protocol or guideline: | Yes |
Year of published/updated protocol: | 2018 |
Target age (min-max) and screening interval [months] for each test: | FIT (50-74 years / [24 months]) |
Invitations for screening and further assessment | |
Initiatives to create population awareness by the Health Ministry/Health Authority: | Mass media campaign Small media campaign Group education Dedicated website Social media platform |
Invitations to eligible population: | No |
Source of the eligible individuals identified: | - |
Method of invitation: | - |
Screening kit included with the invitation: | - |
Screen positive individuals actively contacted for further assessment: | No |
Individuals with a precancer or cancer diagnosis actively contacted: | No |
Quality Assurance (QA) of screening activities | |
Documented standard operating procedure/policy for QA: | No |
An individual/team/institution responsible for QA: | No |
Accreditation of endoscopy units: | No |
Accreditation of pathology services: | No |
Documented performance indicators: | Yes |
Reference standards for performance indicators: | No |
Evaluation reports published in the last five years: | No |
Performance indicators | |
Reporting year for quantitative data: | 2019 |
Source of quantitative data: | directly from programme |
FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
Target age and regional limitation if applicable: | 50-74 years | |||
Invitation coverage (%): | ||||
Participation rate (%): | ||||
Examination coverage (%): | 15.7 | |||
Completeness of data related to screening results (%): | 100.0 | |||
Completeness of data related to information about attendance to colonoscopy assessment (%): | ||||
Further assessment (diagnosis colonoscopy) rate (%): | 27.2 | |||
Further assessment participation rate (%): | ||||
Detection rate of adenomas (x 1000): | ||||
Detection rate of advanced adenomas (x 1000): | ||||
Detection rate of colorectal cancers (x 1000): | ||||
Positive Predictive Value of further assessment to detect adenomas (%): | ||||
Positive Predictive Value of further assessment to detect advanced adenomas (%): | ||||
Positive Predictive Value of further assessment to detect colorectal cancers (%): | ||||
More quantitative data (Both - 2019/FIT) |
Check also the following factsheets: Uruguay, Breast, Cervical